Hamilton Thorne (TSX:HTL) Net Change in Cash : C$-11.12 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Hamilton Thorne's Net Change in Cash for the three months ended in Mar. 2024 was C$-3.02 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was C$-11.12 Mil.

Hamilton Thorne Net Change in Cash Historical Data

The historical data trend for Hamilton Thorne's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Net Change in Cash Chart

Hamilton Thorne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-1.15

11.57

-5.00

-1.70

-9.31

Hamilton Thorne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-1.08	1.13	-1.44	-7.79	-3.02

Hamilton Thorne Net Change in Cash Calculation

Hamilton Thorne's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	5.346	+	-23.474	+	8.479	+	0.341
	=	-9.31

Hamilton Thorne's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0.877 + -2.691 + -1.038 + -0.166

= -3.02

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-11.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamilton Thorne Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Hamilton Thorne's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamilton Thorne (TSX:HTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Net Change in Cash

Comparable Companies

TSX:PRN TSX:QIPT XCNQ:BLO TSXV:TLT TSXV:VPT TSXV:PINK TSXV:NGMD TSXV:MDX TSXV:ASG TSXV:EVMT ABT SYK BSX MDT XTER:SHL EW DXCM SZSE:300760 XAMS:PHIA ZBH

Traded in Other Exchanges

HTLZF:USA 0ZM:Germany

Address

100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915

Website

https://www.hamiltonthorne.ltd

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Executives

Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines